Augmentation of 5-fluoro-2'-deoxyuridine cytotoxicity by 5-phenethyl-2'-deoxyuridine in human gastric cancer cells in culture. 1994

R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
Chemotherapy Division, National Cancer Center Research Institute, Tokyo, Japan.

5-Phenethyl-2'-deoxyuridine (PEUdR) augmented 5-fluoro-2'-deoxyuridine (FUdR) cytotoxicity up to 100-fold in several human gastric cancer cell lines. PEUdR also potentiated 5-fluorouracil (5-FU) cytotoxicity about 5-fold. In contrast, PEUdR reversed 5-fluorouridine (FUR) cytotoxicity in all cell lines studied. PEUdR was not cytotoxic up to 200 microM. PEUdR inhibited the incorporation of [3H]thymidine and [14C]uridine into acid-insoluble fractions, and also inhibited uptake of [3H]thymidine into KATO III cells. Thus, PEUdR inhibits pyrimidine nucleoside transport and salvage enzymes, which potentiates the cytotoxicity of FUdR and reverses the effect of FUR in human gastric cancer cells. These results may contribute to more effective cancer chemotherapy with FUdR and 5-FU.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm

Related Publications

R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
January 1990, Anticancer research,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
May 1988, Proceedings of the National Academy of Sciences of the United States of America,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
September 1974, Journal of medicinal chemistry,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
November 1985, Biochemical pharmacology,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
July 1997, International journal of radiation biology,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
January 1991, Journal of nuclear biology and medicine (Turin, Italy : 1991),
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
November 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
January 1966, Journal of medicinal chemistry,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
February 1978, Proceedings of the National Academy of Sciences of the United States of America,
R Tokuzen, and T Yamaguchi, and M Saneyoshi, and M Yoshida, and M Maeda
December 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!